Summary
Overview
Work History
Education
Personal Information
Accomplishments
Publications
Interests
Languages
Timeline
Generic
Dr. Ameya Kunte

Dr. Ameya Kunte

Specialist For Internal Medicine, Haematology & Oncology
Passau

Summary

Board certified Hematologist and Oncologist in Germany and Austria with Focus and interest in Bone Marrow Transplant and CAR T Cell Therapy. Vigorous training in Internal Medicine and Haematology & Oncology at premier institutes in Germany and Austria, with up-to-date knowledge in managing various hematological disorders with evidence-based practice.

Overview

10
10
years of professional experience

Work History

Attending Physician in Hematology and Stem Cell Transplant

Ordensklinikum Linz Elisabethinen
01.2024 - Current
  • Diagnose and manage hematologic disorders
  • Perform stem cell transplants and CAR T-cell therapies
  • Manage complications like graft-versus-host disease
  • Lead multidisciplinary teams for optimal care
  • Participate in tumor boards and case discussions
  • Lead and contribute to clinical trials and research
  • Mentor trainees and educate the medical team.

Specialist Doctor in Department of Stem Cell Transplantation

University medical center Hamburg-Eppendorf
01.2021 - 12.2023
  • Diagnosing and managing inpatients and outpatients with hematological malignancies and those undergoing autologous and allogeneic BMT and CAR-T Cell Therapy
  • Rotation postings in indoor wards, OPD, BMT daycare, and the apheresis unit
  • Active Participation in Interdisciplinary Tumorboards
  • Undergraduate and postgraduate teaching for the students posted at the BMT department
  • Administrative work such as SOP Establishment and updating, Rotation Planing
  • Antibiotic Stewardship.

Resident Doctor

Saarland University medical center
09.2017 - 12.2020
  • Basic and advanced training in internal medicine and hematology & oncology with vast exposure to BMT
  • Rotation in various departments such as ICU and ED as per training program
  • Worked in the hematological Lab for Cytology, Flow Cytometry, and Cytogenetics of benign and malignant hematological diseases.

Resident Doctor

St. Ansgar Hospital
11.2016 - 08.2017
  • Basic training in internal medicine.

Resident Doctor

Center for Cancer, Kokilaben Ambani Hospital and medical research center
07.2015 - 03.2016

Responsible for management of inpatients and outpatients in Center for Cancer

Resident Doctor

Jaslok Hospital and research center
10.2014 - 06.2015
  • First experience in hematology, oncology, and BMT.

Education

Specialist - Int. Medicine, Haematology & Oncology -

University Medical Center Hamburg Eppendorf, DE
Hamburg, Germany
04.2001 -

MD in General Medicine -

Ryazan State I. P. Pavlov Medical University
Ryazan
10.2006 - 2012.05

Internship -

Jaslok Hospital and research center
Mumbai
06.2013 - 2014.05

Personal Information

  • Place of Birth: Panvel, India
  • Date of Birth: 27 Feb. 1988
  • Nationality: German
  • Marital Status: Married

Accomplishments

    07/2023 Antibiotic Stewardship (ABS-Expert)

    12/2022 Porter and Oral presentation at ASH annual Meeting, New Orleans, USA

    09/2022 Poster Presentation at EBMT Transplant-Course Barcelona, Spain

    07/2022 EHA Masterclass in clinical Haematology

    08/2019 ESMO Academy Oxfard, UK

    05/2019 Poster presentation at ESMO Preceptorship on Immuno-Oncology Zürich, Switzerland

    03/2019 ESMO- The Christie Preceptorship on Lung Cancer, Manchester, UK

    03/2018 ESMO-ESO Masterclass in Clinical Oncology, Berlin, Germany

Publications

Viral Reactivation and Immune Reconstitution after CAR-T Cell Treatment in Patients with Hematologic Malignancies

Ameya Shrinivas Kunte , Nico Gagelmann, Anita Badbaran,Carolina Berger, Radwan Massoud, Evgeny Klyuchnikov,Christine Wolschke, Dietlinde Janson,Ulrike Fritsche-Friedland, Boris Fehse, Nicolaus Kroeger,Francis A. Ayuk. Blood (2022) 140 (Supplement 1): 7531–7532.

Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation

Normann Steiner, Radwan Massoud, Evgeny Klyuchnikov, Nico Gagelmann, Ameya Kunte , Johanna Richter, Christian Niederwieser, Kristin Rathje, Tatjana Urbanowicz, Janik Engelmann, Christina Ihne, Iryna Lastovytska, Cecilia Lindhauer, Franziska Marquard, Mirjam Reichard, Alla Ryzhkova, Rusudan Sabauri, Mathias Schäfersküpper, Niloufar Seyedi, Georgios Kalogeropoulos, Silke Heidenreich, Ina Rudolph, Gaby Zeck, Dietlinde Janson, Christine Wolschke, Francis Ayuk & Nicolaus Kröger .Bone Marrow Transplantation volume 59 , pages 1265–1274 (2024)

Multidisciplinary survey on use of feeding tubes in head and neck cancer patients undergoing chemoradiotherapy in Germany—the SUFEETUBE project

Anastassia Löser MD, PhD, Alexander Fabian, Alexander Rühle, Alexander Thieme, Andrea Baehr, Lukas Käsmann, Inga Zwaan, Birte Kahle, Tamer Soror, Ameya Kunte , Niloufar Seyedi, Maxim Kebenko, Christoph Seidel, Friederike Dierks, Linda Krause, Karl-Ludwig Bruchhage & Dirk Rades Strahlenther Onkol 200, 583–594 (2024).

Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation

Sofia Oechsler, Nico Gagelmann, Christine Wolschke, Dietlinde Janson, Anita Badbaran, Evgeny Klyuchnikov, Radwan Massoud, Kristin Rathje, Johanna Richter, Mathias Schäfersküpper, Christian Niederwieser, Ameya Kunte , Silke Heidenreich, Francis Ayuk & Nicolaus Kröger. Bone Marrow Transplant 59 , 550–557 (2024)

Sequential Conditioning Does Not Improve Outcomes of Allogeneic Stemcell Transplantation in CMML Patients

Radwan Massoud, Evgeny Klyuchnikov, Ameya Shrinivas Kunte , Christian Niederwieser,Dietlinde Janson, Christine Wolschke, Francis A. Ayuk,Nicolaus Kröger. Blood (2023) 142 (Supplement 1): 2156.

The Impact of Anti-T-Lymphocyte-Globulin Dosing on Gvhd in Matched Sibling Allogeneic Stemcell Transplantation

Radwan Massoud, Ameya Shrinivas Kunte ,Evgeny Klyuchnikov, Anita Badbaran,Christian Niederwieser, Dietlinde Janson,Christine Wolschke, Francis A. Ayuk, Nicolaus Kröger. Blood (2023) 142 (Supplement 1): 7014.

Mutation Clearance of Driver Mutations after Transplantation for Myelofibrosis Predicts Outcome

Nico Gagelmann, Marie Quarder, Anita Badbaran,Christine Wolschke, Kristin Rathje,Mathias Schäfersküpper, Ameya Shrinivas Kunte ,Evgeny Klyuchnikov, Radwan Massoud, Johanna Richter,Dietlinde Janson, Boris Fehse, Francis A. Ayuk,Nicolaus Kroeger. Blood (2023) 142 (Supplement 1): 630.

Interests

Photography, Drone Photography, Bicycle Sport, Cooking, Trekking

Languages

English
Advanced (C1)
German
Bilingual or Proficient (C2)
Russian
Advanced (C1)
Hindi
Bilingual or Proficient (C2)
Marathi
Bilingual or Proficient (C2)
Luxembourgish
Upper intermediate (B2)

Timeline

Attending Physician in Hematology and Stem Cell Transplant

Ordensklinikum Linz Elisabethinen
01.2024 - Current

Specialist Doctor in Department of Stem Cell Transplantation

University medical center Hamburg-Eppendorf
01.2021 - 12.2023

Resident Doctor

Saarland University medical center
09.2017 - 12.2020

Resident Doctor

St. Ansgar Hospital
11.2016 - 08.2017

Resident Doctor

Center for Cancer, Kokilaben Ambani Hospital and medical research center
07.2015 - 03.2016

Resident Doctor

Jaslok Hospital and research center
10.2014 - 06.2015

Internship -

Jaslok Hospital and research center
06.2013 - 2014.05

MD in General Medicine -

Ryazan State I. P. Pavlov Medical University
10.2006 - 2012.05

Specialist - Int. Medicine, Haematology & Oncology -

University Medical Center Hamburg Eppendorf, DE
04.2001 -
Dr. Ameya KunteSpecialist For Internal Medicine, Haematology & Oncology